AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32248355 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumferential Heller myotomy
Number of subjects: 20
Study 32248355 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Heller myotomy with Dor fundoplication (Control)
Number of subjects: 20
Study 613264089 — intervention group
Group type: EXPERIMENTAL
Intervention: Theater Alive
Number of subjects: 178
Study 613264089 — intervention group
Group type: EXPERIMENTAL
Intervention: NUT + MEF + MEM + ML
Number of subjects: 178
Study 613264089 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 178
Study 35101116 — intervention group
Group type: EXPERIMENTAL
Intervention: DUDE conducted by trained clinical psychologists (N = 800; 4 schools)
Number of subjects: 3200
Study 35101116 — intervention group
Group type: EXPERIMENTAL
Intervention: DUDE conducted by trained teachers (N = 800; 4 schools)
Number of subjects: 3200
Study 35101116 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention 'Stress-free through the school day' (active control group, N = 1600; 8 schools)
Number of subjects: 3200
Study 33902551 — intervention group
Group type: EXPERIMENTAL
Intervention: SA (alumina sandblasted and acid‐etched) implants
Number of subjects: 75
Study 33902551 — intervention group
Group type: EXPERIMENTAL
Intervention: NH (bioabsorbable apatite nanocoating) implants
Number of subjects: 75
Study 33902551 — intervention group
Group type: EXPERIMENTAL
Intervention: SLA (large‐grit sandblasted and acid‐etched) implants
Number of subjects: 75
Study 33217396 — intervention group
Group type: EXPERIMENTAL
Intervention: PRBC transfusion
Number of subjects: 1660
Study 33217396 — intervention group
Group type: COMPARATOR
Intervention: No PRBC transfusion
Number of subjects: 1660
Study 32273317 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based lifestyle interventions
Number of subjects: 180
Study 32273317 — intervention group
Group type: COMPARATOR
Intervention: Text messages containing health information
Number of subjects: 180
Study 35139816 — intervention group
Group type: EXPERIMENTAL
Intervention: fremanezumab quarterly
Number of subjects: 928
Study 35139816 — intervention group
Group type: EXPERIMENTAL
Intervention: fremanezumab monthly
Number of subjects: 928
Study 35139816 — intervention group
Group type: EXPERIMENTAL
Intervention: fremanezumab (total)
Number of subjects: 928
Study 35139816 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 928
Study 34516557 — intervention group
Group type: EXPERIMENTAL
Intervention: Microclinic intervention
Number of subjects: 304
Study 34200618 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise with heavy loads
Number of subjects: 10
Study 34200618 — intervention group
Group type: COMPARATOR
Intervention: Resistance exercise with light/moderate load
Number of subjects: 10
Study 32311763 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 0
Study 32311763 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir and ritonavir
Number of subjects: 0
Study 32311763 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir and ritonavir + interferon
Number of subjects: 0
Study 32311763 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine or hydroxychloroquine
Number of subjects: 0
Study 34788900 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate
Number of subjects: 112
Study 34788900 — intervention group
Group type: COMPARATOR
Intervention: Bipolar transurethral resection of the prostate
Number of subjects: 112
Study 33906842 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐F NDS use (combustion-free nicotine delivery systems)
Number of subjects: 576
Study 33906842 — intervention group
Group type: COMPARATOR
Intervention: Referral to smoking cessation programmes
Number of subjects: 576
Study 36169608 — intervention group
Group type: COMPARATOR
Intervention: Control Group 1: diprospan combined with mucopolysaccharide polysulphate cream
Number of subjects: 80
Study 36169608 — intervention group
Group type: COMPARATOR
Intervention: Control Group 2: isotopic phosphorus‐32 dressing combined with mucopolysaccharide polysulphate cream
Number of subjects: 80
Study 36169608 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Group: isotopic phosphorus‐32 dressing combined with diprospan and mucopolysaccharide polysulphate cream
Number of subjects: 80
Study 35256232 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe plus lifestyle and dietary intervention (eze)
Number of subjects: 40
Study 35256232 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle and dietary intervention alone (placebo)
Number of subjects: 40
Study 33306562 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer change agent type I network intervention, including an opinion leader workshop with telephonic booster sessions.
Number of subjects: 423
Study 33306562 — intervention group
Group type: COMPARATOR
Intervention: Control group (time-matched control).
Number of subjects: 423
Study 32401733 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 60
Study 32401733 — intervention group
Group type: COMPARATOR
Intervention: Non-NPWT treatment (petrolatum gauze and Bogota bag)
Number of subjects: 60
Study 616875726 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial and peripheral magnetic stimulation
Number of subjects: 74
Study 616875726 — intervention group
Group type: COMPARATOR
Intervention: Placebo repetitive transcranial and peripheral magnetic stimulation
Number of subjects: 74
Study 35997729 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT alone (n=172)
Number of subjects: 341
Study 35997729 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (IMRT with cisplatin, 100 mg/m2 every 3 weeks for 3 cycles) (n=169)
Number of subjects: 341
Study 35997729 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (n=169)
Number of subjects: 341
Study 33965518 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive Parenting
Number of subjects: 62
Study 33965518 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 62
Study 32252725 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified fixation group
Number of subjects: 52
Study 32252725 — intervention group
Group type: COMPARATOR
Intervention: Conventional fixation group
Number of subjects: 52
Study 32252725 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study 34346273 — intervention group
Group type: EXPERIMENTAL
Intervention: WBV plus hip-knee strengthening (WHK group)
Number of subjects: 36
Study 34346273 — intervention group
Group type: COMPARATOR
Intervention: hip-knee strengthening only (HK group)
Number of subjects: 36
Study 34930386 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttreatment CA-125 level > 10 U/ml
Number of subjects: 97
Study 34930386 — intervention group
Group type: COMPARATOR
Intervention: Posttreatment CA-125 level ≤ 10 U/ml
Number of subjects: 97
Study 33616188 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated collaborative care
Number of subjects: 409
Study 33616188 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 409
Study 32503520 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (less than 10% 25-OHD)
Number of subjects: 1232
Study 32503520 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (between 10% and 90% 25-OHD)
Number of subjects: 1232
Study 32503520 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (greater than 90% 25-OHD)
Number of subjects: 1232
Study 35964621 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-based follow-up (clinic visits, chest x-rays, thoraco-abdominal CT scans, and fibre-optic bronchoscopy for non-adenocarcinoma histology)
Number of subjects: 1775
Study 35964621 — intervention group
Group type: COMPARATOR
Intervention: Minimal follow-up (visits and chest x-rays)
Number of subjects: 1775
Study 33662051 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral optical scanning (IOS)
Number of subjects: 38
Study 33662051 — intervention group
Group type: COMPARATOR
Intervention: Conventional impressions (polyether)
Number of subjects: 38
Study 33662051 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall restoration survival rate
Number of subjects: 38
Study 33662051 — intervention group
Group type: EXPERIMENTAL
Intervention: Technical complications
Number of subjects: 38
Study 35256046 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous thoracic paravertebral block with ropivacaine
Number of subjects: 76
Study 35256046 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 76
Study 32937634 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet
Number of subjects: 81
Study 32937634 — intervention group
Group type: COMPARATOR
Intervention: Non-Tourniquet
Number of subjects: 81
Study 32749579 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonated water (250 ml)
Number of subjects: 1000
Study 32749579 — intervention group
Group type: COMPARATOR
Intervention: Plain water (250 ml)
Number of subjects: 1000
Study 35659319 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkasite-based resin composite (Cention N, Ivoclar Vivadent)
Number of subjects: 40
Study 35659319 — intervention group
Group type: COMPARATOR
Intervention: Resin-modified glass ionomer cement (Voco GmbH)
Number of subjects: 40
Study 33736533 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol dispersible tablets
Number of subjects: 0
Study 33736533 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol syrup
Number of subjects: 0
Study 32485640 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep convolutional neural network of ultrasound (DCNN-US)
Number of subjects: 2143
Study 36181584 — intervention group
Group type: EXPERIMENTAL
Intervention: StroVac (3 single intramuscular injections every two weeks)
Number of subjects: 376
Study 36181584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376
Study 36181584 — intervention group
Group type: EXPERIMENTAL
Intervention: StroVac
Number of subjects: 376
Study 33069319 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Brief Exposure (VBE) - repeated presentation of masked phobic stimuli (spiders)
Number of subjects: 82
Study 33069319 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (masked flowers) - Very Brief Exposure (VBF)
Number of subjects: 82
Study 34259895 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified autologous fascial sling technique
Number of subjects: 0
Study 34259895 — intervention group
Group type: COMPARATOR
Intervention: Xenograft
Number of subjects: 0
Study 33241323 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNT/A)
Number of subjects: 40
Study 33241323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32238795 — intervention group
Group type: EXPERIMENTAL
Intervention: EUROACTION intervention (nurse-managed comprehensive cardiovascular disease prevention program)
Number of subjects: 1339
Study 32238795 — intervention group
Group type: EXPERIMENTAL
Intervention: EUROACTION intervention
Number of subjects: 1339
Study 32238795 — intervention group
Group type: COMPARATOR
Intervention: usual care (UC)
Number of subjects: 1339
Study 35488868 — intervention group
Group type: EXPERIMENTAL
Intervention: Target temperature management (TTM) for 24 hours at 33±1°C
Number of subjects: 65
Study 35488868 — intervention group
Group type: EXPERIMENTAL
Intervention: Target temperature management (TTM) for 48 hours at 33±1°C
Number of subjects: 65
Study 33793590 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors influencing market participation
Number of subjects: 393
Study 33793590 — intervention group
Group type: EXPERIMENTAL
Intervention: Price, herd size, off-farm income, distance to market, age of the farmer, cattle fattening, membership in cooperatives, access to market information, farming experience
Number of subjects: 393
Study 34240125 — intervention group
Group type: EXPERIMENTAL
Intervention: hs‐cTnI at 10 ng/L
Number of subjects: 19501
Study 34240125 — intervention group
Group type: EXPERIMENTAL
Intervention: hs‐cTnT at 10 ng/L
Number of subjects: 19501
Study 32053149 — intervention group
Group type: EXPERIMENTAL
Intervention: Castration plus docetaxel, 75 mg/m2, every 3 weeks for 6 cycles
Number of subjects: 475
Study 32053149 — intervention group
Group type: COMPARATOR
Intervention: Castration alone
Number of subjects: 475
Study 34000870 — intervention group
Group type: EXPERIMENTAL
Intervention: Information sheet written in first-person narrative
Number of subjects: 322
Study 34000870 — intervention group
Group type: COMPARATOR
Intervention: Non-narrative information sheet
Number of subjects: 322
Study 34000870 — intervention group
Group type: COMPARATOR
Intervention: No information sheet
Number of subjects: 322
Study 33673371 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Sucrosomial Iron (SI) 60 mg/day for 8 weeks then 30 mg/day for 4 weeks
Number of subjects: 0
Study 33673371 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Ferric Carboxy-Maltose (FCM) 1000 mg at baseline
Number of subjects: 0
Study 35388626 — intervention group
Group type: COMPARATOR
Intervention: Conventional Ventilation (CV)
Number of subjects: 319
Study 35388626 — intervention group
Group type: EXPERIMENTAL
Intervention: High Frequency Oscillation (HFO)
Number of subjects: 319
Study 32056766 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer- or clinician-led group behavioral treatment for 20 weeks
Number of subjects: 323
Study 36014767 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucoraphanin from broccoli (BroccoMax®)
Number of subjects: 42
Study 36014767 — intervention group
Group type: EXPERIMENTAL
Intervention: Alliin from garlic (Kwai Heartcare®)
Number of subjects: 42
Study 36014767 — intervention group
Group type: COMPARATOR
Intervention: Control group (no glucoraphanin or alliin supplements)
Number of subjects: 42
Study 32352949 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 0
Study 32352949 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 0
Study 32352949 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Number of subjects: 0
Study 32352949 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-pharmacological methods
Number of subjects: 0
Study 33211349 — intervention group
Group type: EXPERIMENTAL
Intervention: EMF exposure (50 Hz, 28 μT, linear polarized, continuous)
Number of subjects: 34
Study 33211349 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 34
Study 32718787 — intervention group
Group type: EXPERIMENTAL
Intervention: Buddy taping
Number of subjects: 72
Study 32718787 — intervention group
Group type: COMPARATOR
Intervention: Cast immobilization
Number of subjects: 72
Study 35526570 — intervention group
Group type: EXPERIMENTAL
Intervention: WATCHMAN FLX device
Number of subjects: 1600
Study 35526570 — intervention group
Group type: COMPARATOR
Intervention: Oral anticoagulation (control)
Number of subjects: 1600
Study 33616652 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide induction (15 mg orally on days 1-21)
Number of subjects: 780
Study 33616652 — intervention group
Group type: COMPARATOR
Intervention: Idarubicine‐cytarabine (cycle 1) and daunorubicin and intermediate‐dose cytarabine (cycle 2) without lenalidomide
Number of subjects: 780
Study 33616652 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance with lenalidomide (10 mg on days 1-21)
Number of subjects: 780
Study 33616652 — intervention group
Group type: COMPARATOR
Intervention: Observation (control for maintenance phase)
Number of subjects: 780
Study 33616652 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide benefit suggested in SRSF2‐mutant AML (exploratory post hoc analysis)
Number of subjects: 780
Study 32175901 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented hemiarthroplasty (CHA)
Number of subjects: 158
Study 32175901 — intervention group
Group type: COMPARATOR
Intervention: Uncemented hemiarthroplasty (UCH)
Number of subjects: 158
Study 35193054 — intervention group
Group type: EXPERIMENTAL
Intervention: SCT630 (40 mg)
Number of subjects: 146
Study 35193054 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab (40 mg)
Number of subjects: 146
Study 34934969 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate plus prednisone (AAP)
Number of subjects: 122
Study 34934969 — intervention group
Group type: EXPERIMENTAL
Intervention: AAP with degarelix
Number of subjects: 122
Study 34934969 — intervention group
Group type: COMPARATOR
Intervention: Degarelix
Number of subjects: 122
Study 34934969 — intervention group
Group type: EXPERIMENTAL
Intervention: AAP
Number of subjects: 122
Study 36240387 — intervention group
Group type: EXPERIMENTAL
Intervention: HOMA‐IR assessment in newborns HEU
Number of subjects: 450
Study 36240387 — intervention group
Group type: COMPARATOR
Intervention: TDF/XTC/DTG in utero ARV exposure
Number of subjects: 450
Study 36240387 — intervention group
Group type: COMPARATOR
Intervention: AZT postnatal prophylaxis
Number of subjects: 450
Study 32000193 — intervention group
Group type: EXPERIMENTAL
Intervention: Video discharge instructions
Number of subjects: 60
Study 32000193 — intervention group
Group type: COMPARATOR
Intervention: Standard discharge instructions
Number of subjects: 60
Study 34937456 — intervention group
Group type: EXPERIMENTAL
Intervention: Rewarded group (n = 19) trained with performance feedback and contingent monetary reward
Number of subjects: 37
Study 34937456 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 18) used the same system without monetary reward and with graphically minimized performance feedback
Number of subjects: 37
Study 33619820 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream applied with expectation of pain reduction after 5 minutes (P5)
Number of subjects: 53
Study 33619820 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream applied with expectation of pain reduction after 30 minutes (P30)
Number of subjects: 53
Study 33619820 — intervention group
Group type: COMPARATOR
Intervention: Cream with no analgesic expectation (NE)
Number of subjects: 53
Study 32228074 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellofemoral arthroplasty (PFA)
Number of subjects: 100
Study 32228074 — intervention group
Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 100
Study 35134818 — intervention group
Group type: EXPERIMENTAL
Intervention: trans‐C16:1n‐7 in isolation
Number of subjects: 62
Study 35134818 — intervention group
Group type: EXPERIMENTAL
Intervention: trans‐C16:1n‐7 combined with iso‐C17:0
Number of subjects: 62
Study 35134818 — intervention group
Group type: EXPERIMENTAL
Intervention: C15:0 and C17:0
Number of subjects: 62
Study 33722864 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct angiosuite transfer (DAT)
Number of subjects: 208
Study 33722864 — intervention group
Group type: COMPARATOR
Intervention: Standard imaging/emergency department-based management
Number of subjects: 208
Study 33722864 — intervention group
Group type: EXPERIMENTAL
Intervention: DAT
Number of subjects: 208
Study 33722864 — intervention group
Group type: COMPARATOR
Intervention: Standard management
Number of subjects: 208
Study 32344384 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated LFCT measurement
Number of subjects: 596
Study 32344384 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 596
Study 32344384 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age (>69)
Number of subjects: 596
Study 32344384 — intervention group
Group type: EXPERIMENTAL
Intervention: Body habitus
Number of subjects: 596
Study 32344384 — intervention group
Group type: EXPERIMENTAL
Intervention: Apnea/hypopnea duration, apnea vs. hypopnea, nadir O2 saturation, sleep stages (N vs. R)
Number of subjects: 596
Study 36264299 — intervention group
Group type: EXPERIMENTAL
Intervention: blended problem-based learning (bPbL)
Number of subjects: 317
Study 36264299 — intervention group
Group type: COMPARATOR
Intervention: conventional problem-based learning (cPbL)
Number of subjects: 317
Study 33531255 — intervention group
Group type: COMPARATOR
Intervention: Testosterone undecanoate (TU) plus placebo (PL)
Number of subjects: 16
Study 33531255 — intervention group
Group type: COMPARATOR
Intervention: Testosterone undecanoate (TU) plus dutasteride (DT)
Number of subjects: 16
Study 35811600 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led preventive oral health education
Number of subjects: 372
Study 35811600 — intervention group
Group type: COMPARATOR
Intervention: Class-based lecture on oral health (Control)
Number of subjects: 372
Study 34057684 — intervention group
Group type: EXPERIMENTAL
Intervention: SEPTIN12 c.474 G > A polymorphism in teratozoospermic patients
Number of subjects: 48
Study 34057684 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-smoking teratozoospermic patients
Number of subjects: 48
Study 34057684 — intervention group
Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 48
Study 34057684 — intervention group
Group type: COMPARATOR
Intervention: Fertile controls
Number of subjects: 48
Study 34665856 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (24 mg oral)
Number of subjects: 12
Study 34665856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 34959874 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-Body Electromyostimulation (WB-EMS)
Number of subjects: 6
Study 34959874 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RES)
Number of subjects: 6
Study 34959874 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling Endurance Exercise (END)
Number of subjects: 6
Study 36008058 — intervention group
Group type: EXPERIMENTAL
Intervention: Slowly absorbable mesh
Number of subjects: 0
Study 36008058 — intervention group
Group type: COMPARATOR
Intervention: Standard care (conventional care including primary closure, non-absorbable synthetic mesh or biologic mesh)
Number of subjects: 0
Study 32326264 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent-graft implantation
Number of subjects: 38
Study 32326264 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthesis implantation
Number of subjects: 38
Study 32326264 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (Prosthesis implantation)
Number of subjects: 38
Study 35640529 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg oral THC
Number of subjects: 25
Study 35640529 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg oral THC
Number of subjects: 25
Study 35640529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 37092240 — intervention group
Group type: EXPERIMENTAL
Intervention: UVC
Number of subjects: 233
Study 37092240 — intervention group
Group type: COMPARATOR
Intervention: PICC
Number of subjects: 233